189.265 articles found

Temporal interference stimulation rescues dopaminergic neurons in the substantia nigra of MPTP-induced Parkinson’s disease mice via inhibition of lipid peroxidation

Sun L, Qin H, Zhou B, Hao Y, Ding Z, He Z, Zheng Y, Zhu Y.

Journal of translational medicine · 2026-01-01

‘To Hear and Be Heard’: The Co‐Design of a Website to Support Communication Challenges Experienced by People With Parkinson's and Their Families and Friends

Cocks N, Thilakaratne R, Mcginley P, Hyland R, Loftus A, Wylie K.

International journal of language & communication disorders · 2026-01-01

Emerging links between gut dysbiosis, aryl hydrocarbon receptor activation, and Parkinson’s disease

Aziz N, Kortagere S.

Communications biology · 2026-01-01

Therapeutic and Diagnostic Implications of Carbon Dot: An Advancement in the Avenue towards Cancer, Diabetes and Neurodegenerative Disorders.

Manna S, Banerjee S, De A, Banerjee S, Das S, Rakshit P, S K AK, Sen KK, De S.

Pharm Nanotechnol · 2026-01-01

DOI: 10.2174/0122117385314533240824090949PMID: 39350419

Navigating into the Paradigm of Nose-to-brain Delivery of Nanotherapeutics and their Repurposing as Nanotheranostics for Neurodegenerative Diseases.

Ali A, Emad NA, Sultana N, Waheed A, Aqil M, Sultana Y, Mujeeb M.

CNS Neurol Disord Drug Targets · 2026-01-01

DOI: 10.2174/0118715273319597240927044906PMID: 39400020

Synthesis of 2,4-bis(trifluoromethyl)benzaldehyde Hybrid Thiosemicarbazones as Prolyl Oligopeptidase Inhibitors for Neurodegenerative Disorders and their In silico Analysis.

Pasha AR, Ullah S, Halim SA, Khan A, Hussain J, El-Kott AF, Naseer MM, Eltantawy W, Al-Harrasi A, Shafiq Z.

Curr Med Chem · 2026-01-01

DOI: 10.2174/0109298673325023240909101327PMID: 39411949

Design, Synthesis, Molecular Docking, Pharmacokinetic Properties, and Molecular Dynamics Simulation of Sulfonyl Derivatives of Benzimidazole against Parkinson's Disease.

Roy S, Basak S, Roy S, Dey P, Barman H, Singh B, Sarkar K, Sen S, Das RK, Debnath S, Biswas G.

Curr Med Chem · 2026-01-01

DOI: 10.2174/0109298673337912241007120510PMID: 39449335

Parkinson's Disease: A Progressive Neurodegenerative Disorder and Structure-Activity Relationship of MAO Inhibitor Scaffolds as an Important Therapeutic Regimen.

Salauddin, Zaidi SAA, Ubaid M, Shamim S, Naim MJ, Khanna S, Alam O.

CNS Neurol Disord Drug Targets · 2026-01-01

DOI: 10.2174/0118715273324300241010054029PMID: 39482908

Sanggenol L Alleviates Rotenone-induced Parkinson's Disease, Inhibits Mitochondrial Complex I <i>Via</i> P13K/AKT/mTOR Signalling.

Zhao N, Wu M, Velu P, Annamalai V, Zhang J.

Comb Chem High Throughput Screen · 2026-01-01

DOI: 10.2174/0113862073358649241128053921PMID: 39679462

The Use of Cannabis-Based Medicine in Selected Neurological Disorders.

Szejko N, Saramak K, Müller-Vahl KR.

Curr Top Behav Neurosci · 2026-01-01

DOI: 10.1007/7854_2024_564PMID: 39739176

α-Phellandrene: A Promising Natural Remedy for Rotenone-Induced Parkinson's Disease.

Kumar R, Arora S, Alam S, Rashid M, Kumar S.

Recent Adv Food Nutr Agric · 2026-01-01

DOI: 10.2174/012772574x341801241218051720PMID: 39886788

Parkinson's Disease: From Bench to Bedside-Advancements in Diagnosis and Therapeutics using Pharmacogenomic Approach.

Suhas M, Kadiri SK.

Curr Gene Ther · 2026-01-01

DOI: 10.2174/0115665232342211250207064205PMID: 39945257